{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T00:51:58Z","timestamp":1789865518128,"version":"4.0.1"},"reference-count":9,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Ophthalmol"],"published-print":{"date-parts":[[2012]]},"DOI":"10.4103\/0301-4738.98714","type":"journal-article","created":{"date-parts":[[2012,7,19]],"date-time":"2012-07-19T08:52:38Z","timestamp":1342687958000},"page":"315","source":"Crossref","is-referenced-by-count":38,"title":["Desferrioxamine-related ocular toxicity: A case report"],"prefix":"10.4103","volume":"60","author":[{"given":"Sumu","family":"Simon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"PaulA","family":"Athanasiov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajeev","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grant","family":"Raymond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JagjitS","family":"Gilhotra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0301-4738.98714-1","doi-asserted-by":"crossref","unstructured":"Weatherall DJ, Clegg JB. The Thalassamia Syndromes. 4 th ed. Oxford: Blackwell Sciences Ltd; 2001.","DOI":"10.1002\/9780470696705"},{"key":"key-10.4103\/0301-4738.98714-2","first-page":"739","volume-title":"Iron-chelating therapy and the treatment of thalassemia","author":"Olivieri","year":"1997","journal-title":"Blood"},{"key":"key-10.4103\/0301-4738.98714-3","first-page":"386","volume-title":"Desferrioxamine related maculopathy: A case report","author":"Arora","year":"2004","journal-title":"Am J Hematol"},{"key":"key-10.4103\/0301-4738.98714-4","first-page":"181","volume-title":"Ocular toxicity of high-dose intravenous desferrioxamine","author":"Davies","year":"1983","journal-title":"Lancet"},{"key":"key-10.4103\/0301-4738.98714-5","first-page":"164","volume-title":"The expanded clinical spectrum of deferoxamine retinopathy","author":"Haimovici","year":"2002","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0301-4738.98714-6","first-page":"1229","volume-title":"Long-term outcome of continuous 24-hour deferoxamine infusion via indwelling intravenous catheters in high-risk beta-thalassemia","author":"Davis","year":"2000","journal-title":"Blood"},{"key":"key-10.4103\/0301-4738.98714-7","first-page":"407","volume-title":"A risk-benefit assessment of iron-chelation therapy","author":"Porter","year":"1997","journal-title":"Drug Saf"},{"key":"key-10.4103\/0301-4738.98714-8","first-page":"243","volume-title":"Rapid development of severe toxic retinopathy associated with continuous intravenous deferoxamine infusion","author":"Lai","year":"2006","journal-title":"Br J Ophthalmol"},{"key":"key-10.4103\/0301-4738.98714-9","first-page":"403","volume-title":"Desferrioxamine ototoxicity: Evaluation of risk factors in thalassaemic patients and guidelines for safe dosage","author":"Porter","year":"1989","journal-title":"Br J Haematol"}],"container-title":["Indian Journal of Ophthalmology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T14:58:00Z","timestamp":1786633080000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/0301-4738.98714"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012]]},"references-count":9,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012]]}},"alternative-id":["98714"],"URL":"https:\/\/doi.org\/10.4103\/0301-4738.98714","relation":{},"ISSN":["0301-4738"],"issn-type":[{"value":"0301-4738","type":"print"}],"subject":[],"published":{"date-parts":[[2012]]}}}